$BDTX 3 SEC Filings

Filed On	Filing
12 Apr 2024	Form 3: Campbell Shannon, Director No securities owned
12 Apr 2024	Form 3: Raman Prakash, Director No securities owned
15 Jun 2022	Form 3: Yurasov Sergey, CHIEF MEDICAL OFFICER
13 Apr 2022	Form 3: Biotech Growth N V, 10% owner and 1 other Holds 3,735,846 shares of Common Stock
07 Apr 2022	Form 3: Dixon Wendy L, Director No securities owned
29 Nov 2021	Form 3: Jones Erika, See Remarks
29 Nov 2021	Form 3: Ni Fang, See Remarks Holds 44,026 shares of Common Stock
17 Sep 2021	Form 3: Buck Elizabeth, Chief Scientific Officer Holds 95,192 shares of Common Stock
11 Aug 2021	Form 3: Velleca Mark A., Director No securities owned
22 Jan 2021	Form 3: Dhingra Kapil, Director Holds 10,000 shares of Common Stock
29 Sep 2020	Form 3: Ingram Robert Alexander, Director No securities owned
10 Sep 2020	Form 3: Humphrey Rachel, Chief Medical Officer No securities owned
29 Jan 2020	Form 3: Flynn James E, 10% owner and 3 others
29 Jan 2020	Form 3: Walker Paul Edward, 10% owner
29 Jan 2020	Form 3: Sonsini Peter W., 10% owner
29 Jan 2020	Form 3: Sandell Scott D, 10% owner
29 Jan 2020	Form 3: Mott David M, 10% owner
29 Jan 2020	Form 3: Makower Joshua, 10% owner
29 Jan 2020	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., 10% owner
29 Jan 2020	Form 3: Versant Venture Capital VI, L.p., 10% owner and 3 others Holds 331,585 shares of Common Stock

Comments